Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR

Chem Biol. 2002 Jan;9(1):79-92. doi: 10.1016/s1074-5521(01)00096-5.

Abstract

NMR spectroscopy was used to characterize the hepatitis C virus (HCV) NS3 protease in a complex with the 24 residue peptide cofactor from NS4A and a boronic acid inhibitor, Ac-Asp-Glu-Val-Val-Pro-boroAlg-OH. Secondary-structure information, NOE constraints between protease and cofactor, and hydrogen-deuterium exchange rates revealed that the cofactor was an integral strand in the N-terminal beta-sheet of the complex as observed in X-ray crystal structures. Based upon chemical-shift perturbations, inhibitor-protein NOEs, and the protonation state of the catalytic histidine, the boronic acid inhibitor was bound in the substrate binding site as a transition state mimic. In the absence of cofactor, the inhibitor had a lower affinity for the protease. Although the inhibitor binds in the same location, differences were observed at the catalytic site of the protease.

MeSH terms

  • Binding Sites
  • Boronic Acids / chemistry*
  • Boronic Acids / pharmacology
  • Carrier Proteins / chemistry*
  • Crystallography, X-Ray
  • Hepacivirus / enzymology*
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Magnetic Resonance Spectroscopy
  • Protease Inhibitors / chemistry*
  • Protease Inhibitors / pharmacology
  • Viral Nonstructural Proteins / chemistry*
  • Viral Nonstructural Proteins / metabolism*
  • Viral Proteins / chemistry*

Substances

  • Boronic Acids
  • Carrier Proteins
  • Intracellular Signaling Peptides and Proteins
  • NS3 protein, hepatitis C virus
  • NS4A cofactor peptide, Hepatitis C virus
  • Protease Inhibitors
  • Viral Nonstructural Proteins
  • Viral Proteins